Latest Medtech News
Momentis Surgical has received FDA 510(k) clearance for the multiport configuration of its Anovo® Surgical System, making it the first robotic platform designed to support natural orifice, single-port, and multiport surgical approaches on a single system.
The expanded clearance increases the flexibility of Anovo’s robotic surgery platform, allowing surgeons to use the same system across different minimally invasive procedures while reducing the need for multiple robotic platforms. The technology features flexible, internally articulated robotic instruments designed to improve dexterity and reduce the limitations associated with conventional rigid robotic systems.
“From the beginning, our vision was never to build another robotic system that simply replicated laparoscopy,” said Dvir Cohen, CEO of Momentis Surgical. “This clearance represents another important step toward that vision by giving surgeons the flexibility to choose the appropriate surgical approach for the patients’ benefit while using the same compact robotic platform.”
The company said the expanded indication is expected to support broader adoption across hospitals and ambulatory surgery centers by offering a more modular and cost-efficient approach to robotic surgery.
